Human conjunctival mast cell responses in vitro to various secretagogues

Ocular Immunology and Inflammation

Volumn 4, Issue 1, 1996, Pages 39-50

  Miller, Steven ^a   Cook, Ellen ^b   Graziano, Frank ^b   Spellman, Joan ^a   Yanni, John ^a  

^a ALCON RESEARCH LTD   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Conjunctival; Human; Mast cells; Mediator release; Secretagogues

Indexed keywords

CALCIMYCIN; COLLAGENASE; COMPOUND 48-80; CONCANAVALIN A; HISTAMINE; HYALURONIDASE; IMMUNOGLOBULIN E ANTIBODY; MORPHINE; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN D2; SUBSTANCE P; TOLONIUM CHLORIDE; TRYPTASE;

ARTICLE; CONJUNCTIVA; HISTAMINE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAST CELL; RADIOIMMUNOASSAY;

EID: 0030035049     PISSN: 09273948     EISSN: None     Source Type: Journal    
DOI: 10.3109/09273949609069126     Document Type: Article

References (29)

1. Katz HR, Stevens RL, Austen KF. Heterogeneity of mammalian mast cells differentiated in vivo and in vitro. J Allergy Clin Immunol 1985; 76:250-259.
2. Irani AMA, Schwartz LB. Mast cell heterogeneity. Clin Exp Allergy 1989; 19:143-155.
3. Church MK, Pao GJK, Holgate ST. Characterization of histamine secretion from mechanically dispersed human lung mast cells: effects of anti-IgE, calcium ionophore A23187, compound 48/80, and basic polypeptides. J Immunol 1982; 129:2116-2121.
4. Schulman ES, MacGlashan DW Jr, Peters SP, Schleimer RP, Newball HH, Lichtenstein LM. Human lung mast cells: purification and characterization. J Immunol 1982; 129:2662-2667.
5. Befus AD, Dyck N, Goodacre R, Bienenstock J. Mast cells from the human intestinal lamina propria: isolation, histochemical subtypes, and functional characterization. J Immunol 1987; 138:2604-2610.
6. Benyon RC, Lowman MA, Church MK. Human skin mast cells: their dispersion, purification and secretory characterization. J Immunol 1987; 138:861-867.
7. Wardlaw AJ, Cromwell O, Celestino D, Fitzharris P, Geddes DM, Collins JV, Kay AB. Morphological and secretory properties of bronchoalveolar lavage mast cells in respiratory diseases. Clin Allergy 1986; 16:163-173.
8. Allansmith MR, Ross RN. Ocular allergy. Clin Allergy 1988; 18:1-13.
9. Bielory L, Frohman LP. Allergic and immunologic disorders of the eye. J Allergy Clin Immunol 1992; 89:1-15.
10. T and MCTC in vernal conjunctivitis and giant papillary conjunctivitis. J Allergy Clin Immunol 1990; 86:34-40.
11. Morgan SJ, Williams JH, Walls AF, Church MK, Holgate ST, McGill JI. Mast cell numbers and staining characteristics in the normal and allergic human conjunctiva. J Allergy Clin Immunol 1991; 87:111-116.
12. Proud D, Sweet J, Stein P, Settipane RA, Kagey-Sobotka A, Friedlaender MH, Lichtenstein LM. Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. J Allergy Clin Immunol 1990; 85:896-905.
13. Udell IJ, Abelson MB. Animal and human ocular surface response to a topical nonimmune mast cell degranulating agent (compound 48/80). Am J Ophthalmol 1981; 2:226-230.
14. Undem BJ, Brendel JB, Hirth T, Buckner CK, Graziano FM. Comparative studies of mediator release from guinea pig lung mast cells and basophils. Am Rev Respir Dis 1986; 133:763-768.
15. Siraganian, RP. An automated continuous flow system for the extraction and fluorometric analysis of histamine. Anal Biochem 1974; 57:383-394.
16. Dunnett CW. A multiple comparison procedure for comparing treatments with a control. J Am Stat Assoc 1955; 50:1096-1121.
17. Cabaud PG, Wroblewski F. Colorimetric measurement of lactic dehydrogenase activity of body fluids. Am J Clin Pathol 1958; 30:234-236.
18. Tharp MD, Kagey-Sobotka A, Fox CC, Marone G, Lichtenstein LM, Sullivan TJ. Functional heterogeneity of human mast cells from different anatomic sites: in vitro responses to morphine sulfate. J Allergy Clin Immunol 1987; 79:646-653.
19. Casale TB, Bowman S, Kaliner M. Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: evidence for opiate and nonopiate receptor participation. J Allergy Clin Immunol 1984; 73:775-781.
20. Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986; 83:4464-4468.
21. Schwartz LB. Mediators of human mast cells and human mast cell subsets. Ann Allergy 1987; 58:226-235.
22. Schulman ES, Kagey-Sobotka A, MacGlashan DW Jr, Adkinson NF, Peters SP, Schleimer RP, Lichtenstein LM. Heterogeneity of human mast cells. J Immunol 1983; 131:1936-1941.
23. 2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 1982; 129:1627-1631.
24. MacGlashan DW Jr, Schleimer RP, Peters SP, Schulman ES, Adams GK, Newball HH, Lichtenstein LM. Generation of leukotrienes by purified human lung mast cells. J Clin Invest 1982; 70:747-751.
25. Lawrence ID, Warner JA, Cohan VL, Hubbard WC, Kagey-Sobotka A, Lichtenstein LM. Purification and characterization of human skin mast cells: evidence for human mast cell heterogeneity. J Immunol 1987; 139:3062-3069.
26. Magro AM. Involvement of IgE in con-A induced histamine release from human basophils in vitro. Nature 1974; 249:572-573.
27. Stellato C, Cirillo R, de Paulis A, Casolaro V, Patella V, Mastronardi P, et al. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release. Anesthesiology 1992; 77:932-940.
28. Church MK, Okayama Y, El-Lati S. Mediator secretion from human skin mast cells provoked by immunological and non-immunological stimulation. Skin Pharmacol 1991; 4(suppl 1):15-24.
29. Benyon RC, Robinson C, Church MK. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Br J Pharmacol 1989; 97:898-904.